Answers are grounded in this paper and cite their sources.
Demonstrates enhanced detection capabilities in clinical applications using spherical nanoparticles in LFIAs, indicating improved diagnostic precision.
Lateral flow immunoassay (LFIA), as a core technology of point-of-care testing (POCT), holds significant value in clinical hormone detection, vitamin screening, pathogen diagnosis, and biomarker analysis. Notably, spherical nanomaterials, leveraging...
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: